Hemby S E, Smith J E, Dworkin S I
Department of Physiology and Pharmacology, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, North Carolina, USA.
J Pharmacol Exp Ther. 1996 Jun;277(3):1247-58.
In the first experiment, responding was maintained for food under a fixed ratio (FR) 10 with a 6-min timeout reinforcement schedule. Eticlopride (0.1-1.0 mg/kg i.p.) dose-dependently decreased the number of food pellets obtained, whereas naltrexone (3-30 mg/kg i.p.) did not significantly alter responding. In the second experiment, intravenous self-administration of cocaine (vehicle, 125, 250 and 500 micrograms/infusion), heroin (vehicle, 5.4, 9 and 18 micrograms/infusion) and cocaine/heroin combinations were maintained under a FR10 reinforcement schedule. Cocaine/heroin combinations included the aforementioned cocaine doses combined with 5.4 micrograms/infusion heroin (CH5.4) or 18 micrograms/infusion heroin (CH18). Cocaine/heroin combinations dose-dependently decreased the number of infusions compared with cocaine alone. Eticlopride (0.03-0.3 mg/kg i.p.) decreased self-administration of 125 micrograms/infusion cocaine and increased self-administration of 500 micrograms/infusion cocaine. Self-administration of 250 micrograms/infusion cocaine was increased after 0.03 and 0.1 mg/kg and decreased after 0.3 mg/kg eticlopride. Eticlopride decreased heroin self-administration, an effect which may be attributable to its rate-decreasing effects. Eticlopride partially reversed the downward shift of the CH5.4 group but did not reverse the effect in the CH18 group. Naltrexone (1.0-10.0 mg/kg i.p.) decreased self-administration of 5.4 micrograms/infusion heroin and increased self-administration of 18 micrograms/infusion heroin. Self-administration of 9 micrograms/infusion heroin was increased by 1.0 mg/kg, not affected by 3.0 mg/kg and decreased by 10.0 mg/kg naltrexone. For the CH5.4 and CH18 groups, naltrexone dose-dependently shifted the dose-effect curves toward the cocaine dose-effect curve. Therefore, self-administration of cocaine/heroine combinations can be maintained in the rat and downward shifts in the cocaine dose-effect curve after combination with heroin are mediated through a naltrexone-sensitive mechanism.
在第一个实验中,在固定比率(FR)为10且强化时间表有6分钟超时的条件下,动物为获取食物而做出反应。依托必利(0.1 - 1.0毫克/千克,腹腔注射)剂量依赖性地减少了获得的食物颗粒数量,而纳曲酮(3 - 30毫克/千克,腹腔注射)并未显著改变反应。在第二个实验中,在FR10强化时间表下维持可卡因(溶剂、125、250和500微克/次注射)、海洛因(溶剂、5.4、9和18微克/次注射)以及可卡因/海洛因组合的静脉自我给药。可卡因/海洛因组合包括上述可卡因剂量与5.4微克/次注射海洛因(CH5.4)或18微克/次注射海洛因(CH18)的组合。与单独使用可卡因相比,可卡因/海洛因组合剂量依赖性地减少了注射次数。依托必利(0.03 - 0.3毫克/千克,腹腔注射)减少了125微克/次注射可卡因的自我给药,并增加了500微克/次注射可卡因的自我给药。250微克/次注射可卡因的自我给药在0.03和0.1毫克/千克依托必利后增加,在0.3毫克/千克依托必利后减少。依托必利减少了海洛因的自我给药,这一效应可能归因于其降低速率的作用。依托必利部分逆转了CH5.4组的向下偏移,但未逆转CH18组的效应。纳曲酮(1.0 - 10.0毫克/千克,腹腔注射)减少了5.4微克/次注射海洛因的自我给药,并增加了18微克/次注射海洛因的自我给药。9微克/次注射海洛因的自我给药在1.0毫克/千克时增加,在3.0毫克/千克时不受影响,在10.0毫克/千克纳曲酮时减少。对于CH5.4和CH18组,纳曲酮剂量依赖性地将剂量效应曲线向可卡因剂量效应曲线偏移。因此,可卡因/海洛因组合的自我给药在大鼠中可以维持,并且与海洛因组合后可卡因剂量效应曲线的向下偏移是通过一种对纳曲酮敏感的机制介导的。